A retrospective study of patients' out-of-pocket costs for granulocyte colony-stimulating factors.

about

The implications of out-of-pocket cost of cancer treatment in the USA: a critical appraisal of the literature.

P2860

Q38282454-78BF55F5-E760-47C9-B115-554FD4C0958D

P2860

A retrospective study of patients' out-of-pocket costs for granulocyte colony-stimulating factors.

Item

http://www.wikidata.org/entity/Q38427936

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

A retrospective study of patie ...... te colony-stimulating factors.

@en

type

Item

label

A retrospective study of patie ...... te colony-stimulating factors.

@en

prefLabel

A retrospective study of patie ...... te colony-stimulating factors.

@en

P1476

A retrospective study of patie ...... te colony-stimulating factors.

@en

P2093

An-Chen Fu

http://www.w3.org/2001/XMLSchema#string

Karen Tomic

http://www.w3.org/2001/XMLSchema#string

Richard Barron

http://www.w3.org/2001/XMLSchema#string

Stacey Long

http://www.w3.org/2001/XMLSchema#string

Tzy-Chyi Yu

http://www.w3.org/2001/XMLSchema#string

Xiaoyan Li

http://www.w3.org/2001/XMLSchema#string

P2860

Medical visits for chemotherapy and chemotherapy-induced neutropenia: a survey of the impact on patient time and activities

The impact of frequent injections for hematopoietic growth factor support on patients receiving chemotherapy: an observational study

Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study.

The out of pocket cost of breast cancer survivors: a review.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

Final results of a placebo-controlled study of filgrastim in small-cell lung cancer: exploration of risk factors for febrile neutropenia.

Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions

National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008

P304

328-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1078155212473001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23353712

http://www.w3.org/2001/XMLSchema#string

A retrospective study of patients' out-of-pocket costs for granulocyte colony-stimulating factors.

about

P2860

P2860

A retrospective study of patients' out-of-pocket costs for granulocyte colony-stimulating factors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698